Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study-Reference-Cited by-同舟云学术

Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study

Published:2018-07-06 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Shirakashi Mirei,Yoshifuji Hajime,Kodama Yuzo,Chiba Tsutomu,Yamamoto Motohisa,Takahashi Hiroki,Uchida Kazushige,Okazaki Kazuichi,Ito Tetsuya,Kawa Shigeyuki,Yamada Kazunori,Kawano Mitsuhiro,Hirata Shintaro,Tanaka Yoshiya,Moriyama Masafumi^ORCID,Nakamura Seiji,Kamisawa Terumi,Matsui Shoko,Tsuboi Hiroto,Sumida Takayuki,Shibata Motoko,Goto Hiroshi,Sato Yasuharu,Yoshino Tadashi,Mimori Tsuneyo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-28405-x.pdf

Reference24 articles.

1. Umehara, H. et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod. Rheumatol. 22, 1–14 (2012).

2. Zen, Y. & Nakanuma, Y. IgG4-related disease: a cross-sectional study of 114 cases. Am. J. Surg. Pathol. 34, 1812–1819 (2010).

3. Hamano, H. et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344, 732–738 (2001).

4. Yamamoto, M. et al. Elevated IgG4 concentrations in serum of patients with Mikulicz’s disease. Scand. J. Rheumatol. 33, 432–433 (2004).

5. Hamano, H. et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359, 1403–1404 (2002).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4‐RD patients: A retrospective cohort study over a decade;Journal of Internal Medicine;2024-06-24

2. Secondary Sclerosing Cholangiopathies;Current Hepatology Reports;2024-02-10

3. HLA-DRB1 Is Associated with Therapeutic Responsiveness in IgG4-related Disease;Internal Medicine;2024-01-15

5. Glucocorticoid impact therapy for recurrent IgG4-related disease with diabetes insipidus as the main manifestation: A case report and literature review;Medicine;2023-11-17